← Back to Search
Multidisciplinary Care In Amyotrophic Lateral Sclerosis: A 4-year Longitudinal Observational Study.
Eglė Sukockienė, R. Iancu Ferfoglia, A. Truffert, Anne-Chantal Héritier Barras, L. Genton, V. Viatte, I. Leuchter, M. Escher, Ninon S. Horié, A. Poncet, P. Pasquina, D. Adler, J. Janssens
Published 2020 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Over a four-year period, ALS patients complied with the modalities of the multidisciplinary management follow-up without any drop-outs. The multidisciplinary management structure also contributes to increasing the experience and knowledge of the clinicians involved in managing patients suffering from this rare disease.
This paper references
Respiratory failure in amyotrophic lateral sclerosis.
M. Daras (1984)
[Evaluation of anxiety and depression among patients hospitalized on an internal medicine service].
J. Lépine (1985)
The Hospital Anxiety and Depression Scale.
G. Huston (1987)
Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults.
T. Perneger (1995)
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function
J. Cedarbaum (1999)
Burnand B. Validation et normes du SF-36 dans la population du canton de Vaud. Lausanne: Institut universitaire de médecine sociale et préventive, Raisons de santé
J L Richard (2000)
World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
B R Brooks (2000)
Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
BR Brooks (2000)
Validation et normes du SF-36 dans la population du canton de Vaud. Lausanne: Institut universitaire de médecine sociale et préventive
JL Richard (2000)
Single prediction equation for bioelectrical impedance analysis in adults aged 20--94 years.
U. Kyle (2001)
Disease progression in amyotrophic lateral sclerosis: Predictors of survival
T. Magnus (2002)
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000
B. Traynor (2003)
SF-36 health survey: Manual and interpretation guide
J. Ware (2003)
Management of patients with amyotrophic lateral sclerosis.
S. Pautex (2005)
Multidisciplinary ALS care improves quality of life in patients with ALS
J. van den Berg (2005)
The ALSFRSr predicts survival time in an ALS clinic population
P. Kaufmann (2005)
Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities
A. Chiò (2006)
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial
S. Bourke (2006)
Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study
S. Zoccolella (2007)
The amyotrophic lateral sclerosis center: a model of multidisciplinary management.
Angeli S. Mayadev (2008)
Increasing incidence of ALS in Canterbury, New Zealand
M. Murphy (2008)
SLAP Registry. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study
S Zoccolella (2008)
Incidence of amyotrophic lateral sclerosis in Europe
G. Logroscino (2009)
Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease.
L. Ng (2009)
Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) – a 20-year review: Can we do better?
J. D. Mitchell (2010)
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
L. Wilkins (2010)
Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients.
L. Genton (2011)
Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives
P. Bede (2011)
From symptom onset to a diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND): Experiences of people with ALS/MND and family carers – a qualitative study
M. O'Brien (2011)
Non-invasive ventilation in motor neuron disease: an update of current UK practice
Catherine L O'Neill (2011)
A new member of the multidisciplinary ALS team: The otolaryngologist
A. Rubin (2012)
À propos des recommandations de diagnostic et de prise en charge dans les maladies neuromusculaires
J. Pouget (2012)
Amyotrophic lateral sclerosis.
A. Ludolph (2012)
Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009
M. Pugliatti (2012)
The changing landscape of non-invasive ventilation in amyotrophic lateral sclerosis
S. Bourke (2012)
EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force
P. Andersen (2012)
Prognostic value of efficiently correcting nocturnal desaturations after one month of non-invasive ventilation in amyotrophic lateral sclerosis: A retrospective monocentre observational cohort study
J. Gonzalez-Bermejo (2013)
The changing scene of amyotrophic lateral sclerosis
W. Robberecht (2013)
Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset
O. Kano (2013)
Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature
A. Chiò (2013)
The natural history of motor neuron disease: Assessing the impact of specialist care
T. Aridegbe (2013)
Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options
S. Körner (2013)
Is tracheostomy still an option in amyotrophic lateral sclerosis? Reflections of a multidisciplinary work group.
Anne-Chantal Héritier Barras (2013)
Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995–2010
J. Rooney (2013)
Non-invasive ventilation effectiveness and the effect of ventilatory mode on survival in ALS patients
J. Sancho (2014)
A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland
J. Rooney (2014)
Need and value of case management in multidisciplinary ALS care: A qualitative study on the perspectives of patients, spousal caregivers and professionals
M. Bakker (2015)
Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases
Susan T. Paulukonis (2015)
Should patients with ALS gain weight during their follow-up?
Anne-Chantal Héritier (2015)
Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study
Marie Galvin (2015)
The frontotemporal syndrome of ALS is associated with poor survival
Rosanne Govaarts (2016)
Factors predicting survival in ALS: a multicenter Italian study
A. Calvo (2016)
Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres
B. Marin (2016)
Supportive and symptomatic management of amyotrophic lateral sclerosis
Esther V Hobson (2016)
Prognostic factors for survival in patients with amyotrophic lateral sclerosis: analysis of a multi-centre clinical trial
E. Yates (2016)
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
P. Austin (2016)
Reduced survival in patients with ALS with upper airway obstructive events on non-invasive ventilation
M. Georges (2016)
Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
M. Hinchcliffe (2017)
The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison
Sarah Martin (2017)
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Koji Abe (2017)
Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
K Abe (2017)
ESPEN guideline clinical nutrition in neurology.
R. Burgos (2018)
End-of-life Characteristics and Palliative Care Provision for Patients With Motor Neuron Disease
Hon Wai Benjamin Cheng (2018)
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy
J. Mandrioli (2018)
Clinical characteristics of long‐term survival with noninvasive ventilation and factors affecting the transition to invasive ventilation in amyotrophic lateral sclerosis
T. Hirose (2018)
Patient perspectives on transitioning to amyotrophic lateral sclerosis multidisciplinary clinics
K. Schellenberg (2018)
Assessing Inspiratory Muscle Strength for Early Detection of Respiratory Failure in Motor Neuron Disease: Should We Use MIP, SNIP, or Both?
J. Janssens (2019)
This paper is referenced by
Early advance care planning in amyotrophic lateral sclerosis patients: results of a systematic intervention by a palliative care team in a multidisciplinary management programme - a 4-year cohort study.
Eglė Sukockienė (2021)
Oral function in amyotrophic lateral sclerosis patients: A matched case-control study.
M. Schimmel (2021)
Longitudinal Timed Up and Go Assessment in Amyotrophic Lateral Sclerosis: A Pilot Study
Eglė Sukockienė (2021)